Chennai, October 9, 2025: Tamil Nadu’s Health Minister, M. Subramanian, has strongly criticized the Union and Madhya Pradesh governments for their inaction regarding the Coldrif cough syrup contamination, which has been linked to the deaths of at least 21 children.
The syrup, manufactured by Sresan Pharmaceuticals in Kancheepuram, Tamil Nadu, was found to contain diethylene glycol, a highly toxic chemical. After receiving information from Madhya Pradesh authorities on October 1, the Tamil Nadu government conducted an investigation, confirmed the contamination, and issued a stop production order on October 3.
Minister Subramanian accused both the central and Madhya Pradesh governments of initially dismissing the matter, claiming there was “nothing wrong” with the medicine, which delayed prompt action and potentially put more lives at risk.
In response, Tamil Nadu has suspended two senior drug inspectors for failing to conduct consistent inspections over the past two years. Meanwhile, the Madhya Pradesh police arrested G. Ranganathan, proprietor of Sresan Pharmaceuticals, at his Chennai residence. The company’s license has been temporarily suspended, and further action will be taken after a thorough investigation into the company’s compliance and safety protocols.
Health officials have emphasized the need for stronger regulatory oversight, more frequent inspections, and better coordination between state and central authorities to prevent such tragedies in the future. The incident has sparked public outrage and renewed calls for stricter enforcement of pharmaceutical safety standards across India.